vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and Morningstar, Inc. (MORN). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $644.8M, roughly 1.1× Morningstar, Inc.). On growth, Morningstar, Inc. posted the faster year-over-year revenue change (10.8% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $53.6M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 6.2%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Morningstar, Inc. is an American financial services firm headquartered in Chicago, Illinois, founded by Joe Mansueto in 1984. It provides an array of investment research and investment management services.

DOC vs MORN — Head-to-Head

Bigger by revenue
DOC
DOC
1.1× larger
DOC
$719.4M
$644.8M
MORN
Growing faster (revenue YoY)
MORN
MORN
+7.7% gap
MORN
10.8%
3.1%
DOC
More free cash flow
DOC
DOC
$303.4M more FCF
DOC
$357.0M
$53.6M
MORN
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
6.2%
MORN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DOC
DOC
MORN
MORN
Revenue
$719.4M
$644.8M
Net Profit
$114.0M
Gross Margin
62.9%
Operating Margin
17.4%
24.2%
Net Margin
73.2%
Revenue YoY
3.1%
10.8%
Net Profit YoY
2406.4%
EPS (diluted)
$0.16
$2.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
MORN
MORN
Q1 26
$644.8M
Q4 25
$719.4M
$641.1M
Q3 25
$705.9M
$617.4M
Q2 25
$694.3M
$605.1M
Q1 25
$702.9M
$581.9M
Q4 24
$698.0M
$591.0M
Q3 24
$700.4M
$569.4M
Q2 24
$695.5M
$571.9M
Net Profit
DOC
DOC
MORN
MORN
Q1 26
Q4 25
$114.0M
$115.1M
Q3 25
$-117.1M
$91.6M
Q2 25
$31.7M
$89.0M
Q1 25
$42.8M
$78.5M
Q4 24
$4.5M
$116.9M
Q3 24
$85.9M
$119.7M
Q2 24
$146.0M
$69.1M
Gross Margin
DOC
DOC
MORN
MORN
Q1 26
62.9%
Q4 25
61.1%
Q3 25
58.6%
60.9%
Q2 25
60.2%
61.9%
Q1 25
61.1%
60.2%
Q4 24
60.3%
60.7%
Q3 24
60.0%
60.9%
Q2 24
60.6%
61.1%
Operating Margin
DOC
DOC
MORN
MORN
Q1 26
24.2%
Q4 25
17.4%
24.9%
Q3 25
9.2%
20.7%
Q2 25
5.7%
20.7%
Q1 25
7.7%
19.6%
Q4 24
-2.2%
28.5%
Q3 24
14.1%
20.3%
Q2 24
22.3%
19.0%
Net Margin
DOC
DOC
MORN
MORN
Q1 26
Q4 25
73.2%
18.0%
Q3 25
-16.6%
14.8%
Q2 25
4.6%
14.7%
Q1 25
6.1%
13.5%
Q4 24
0.7%
19.8%
Q3 24
12.3%
21.0%
Q2 24
21.0%
12.1%
EPS (diluted)
DOC
DOC
MORN
MORN
Q1 26
$2.73
Q4 25
$0.16
$2.79
Q3 25
$-0.17
$2.17
Q2 25
$0.05
$2.09
Q1 25
$0.06
$1.82
Q4 24
$0.02
$2.72
Q3 24
$0.12
$2.77
Q2 24
$0.21
$1.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
MORN
MORN
Cash + ST InvestmentsLiquidity on hand
$467.5M
$492.8M
Total DebtLower is stronger
$9.8B
$1.7B
Stockholders' EquityBook value
$7.5B
$1.0B
Total Assets
$20.3B
$4.0B
Debt / EquityLower = less leverage
1.31×
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
MORN
MORN
Q1 26
$492.8M
Q4 25
$467.5M
$528.7M
Q3 25
$91.0M
$40.3M
Q2 25
$89.4M
$38.1M
Q1 25
$70.6M
$47.7M
Q4 24
$119.8M
$551.0M
Q3 24
$180.4M
$48.8M
Q2 24
$106.9M
$48.0M
Total Debt
DOC
DOC
MORN
MORN
Q1 26
$1.7B
Q4 25
$9.8B
Q3 25
$9.1B
$848.9M
Q2 25
$9.0B
$838.8M
Q1 25
$8.9B
$803.7M
Q4 24
$8.7B
$698.6M
Q3 24
$8.6B
$864.7M
Q2 24
$8.6B
$899.6M
Stockholders' Equity
DOC
DOC
MORN
MORN
Q1 26
$1.0B
Q4 25
$7.5B
$1.2B
Q3 25
$7.6B
$1.5B
Q2 25
$7.9B
$1.6B
Q1 25
$8.2B
$1.6B
Q4 24
$8.4B
$1.6B
Q3 24
$8.6B
$1.6B
Q2 24
$8.8B
$1.4B
Total Assets
DOC
DOC
MORN
MORN
Q1 26
$4.0B
Q4 25
$20.3B
$3.6B
Q3 25
$19.6B
$3.6B
Q2 25
$19.8B
$3.6B
Q1 25
$19.8B
$3.6B
Q4 24
$19.9B
$3.5B
Q3 24
$20.0B
$3.6B
Q2 24
$20.2B
$3.4B
Debt / Equity
DOC
DOC
MORN
MORN
Q1 26
1.68×
Q4 25
1.31×
Q3 25
1.20×
0.56×
Q2 25
1.14×
0.52×
Q1 25
1.08×
0.50×
Q4 24
1.04×
0.43×
Q3 24
1.00×
0.55×
Q2 24
0.98×
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
MORN
MORN
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$357.0M
$53.6M
FCF MarginFCF / Revenue
49.6%
8.3%
Capex IntensityCapex / Revenue
124.4%
5.9%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters
$437.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
MORN
MORN
Q1 26
Q4 25
$1.3B
$204.0M
Q3 25
$315.0M
$195.7M
Q2 25
$363.5M
$99.0M
Q1 25
$279.4M
$91.0M
Q4 24
$1.1B
$153.4M
Q3 24
$318.2M
$191.9M
Q2 24
$316.2M
$152.7M
Free Cash Flow
DOC
DOC
MORN
MORN
Q1 26
$53.6M
Q4 25
$357.0M
$161.3M
Q3 25
$160.1M
Q2 25
$62.4M
Q1 25
$58.8M
Q4 24
$333.7M
$112.8M
Q3 24
$155.8M
Q2 24
$120.8M
FCF Margin
DOC
DOC
MORN
MORN
Q1 26
8.3%
Q4 25
49.6%
25.2%
Q3 25
25.9%
Q2 25
10.3%
Q1 25
10.1%
Q4 24
47.8%
19.1%
Q3 24
27.4%
Q2 24
21.1%
Capex Intensity
DOC
DOC
MORN
MORN
Q1 26
5.9%
Q4 25
124.4%
6.7%
Q3 25
5.8%
Q2 25
6.0%
Q1 25
5.5%
Q4 24
105.6%
6.9%
Q3 24
6.3%
Q2 24
5.6%
Cash Conversion
DOC
DOC
MORN
MORN
Q1 26
Q4 25
10.99×
1.77×
Q3 25
2.14×
Q2 25
11.48×
1.11×
Q1 25
6.52×
1.16×
Q4 24
235.43×
1.31×
Q3 24
3.71×
1.60×
Q2 24
2.17×
2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons